Niall Ashfield investigates how cancer cells develop resistance to treatment. By recreating drug resistance in laboratory-grown cancer cells, his research examines the cellular changes that allow tumours to survive therapy. Identifying vulnerabilities in resistant cells could reveal alternative treatments, improve patient outcomes and support collaborations with pharmaceutical companies worldwide.